symmetric dimethylarginine has been researched along with tryptophan in 1 studies
| Studies (symmetric dimethylarginine) | Trials (symmetric dimethylarginine) | Recent Studies (post-2010) (symmetric dimethylarginine) | Studies (tryptophan) | Trials (tryptophan) | Recent Studies (post-2010) (tryptophan) |
|---|---|---|---|---|---|
| 428 | 27 | 314 | 32,762 | 936 | 7,183 |
| Protein | Taxonomy | symmetric dimethylarginine (IC50) | tryptophan (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 2.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, S; Chen, W; Fu, S; Gao, S; Tao, X; Wang, Q; Wen, Y; Xia, T; Xiong, X; Zhang, F | 1 |
1 other study(ies) available for symmetric dimethylarginine and tryptophan
| Article | Year |
|---|---|
Diagnostic value of plasma tryptophan and symmetric dimethylarginine levels for acute kidney injury among tacrolimus-treated kidney transplant patients by targeted metabolomics analysis.
Topics: Acute Kidney Injury; Adult; Antidepressive Agents, Second-Generation; Arginine; China; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Metabolomics; Middle Aged; Plasma; Retrospective Studies; Sensitivity and Specificity; Tacrolimus; Transplant Recipients; Tryptophan; Young Adult | 2018 |